Aroa Biosurgery [ASX:ARX] Posts FY23 Results and Shares FY24 Outlook
Biotech Aroa has released its audited results for the 2023 financial year, hitting targets and achieving its expectations. The company looks ahead with a positive perspective on FY24, with the group providing new guidance today.





